Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids

• Үндсэн зохиолчид: Gill Diamond (Зохиогч), Natalia Molchanova (Зохиогч), Claudine Herlan (Зохиогч), John A. Fortkort (Зохиогч), Jennifer S. Lin (Зохиогч), Erika Figgins (Зохиогч), Nathen Bopp (Зохиогч), Lisa K. Ryan (Зохиогч), Donghoon Chung (Зохиогч), Robert Scott Adcock (Зохиогч), Michael Sherman (Зохиогч), Annelise E. Barron (Зохиогч)
• Формат: Ном
• Хэвлэсэн: MDPI AG, 2021-03-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Viral infections, such as those caused by Herpes Simplex Virus-1 (HSV-1) and SARS-CoV-2, affect millions of people each year. However, there are few antiviral drugs that can effectively treat these infections. The standard approach in the development of antiviral drugs involves the identification of...